<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>57(1)</volume><submitter>Chen Y</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Accumulating evidence has demonstrated that the long non-coding RNA (lncRNA) lymphocytic leukaemia deletion gene 1 (DLEU1) is abnormally overexpressed in many cancer types, including cervical cancer (CC). However, the potential clinical significance of DLEU1 in serum exosomes of patients with CC remains unclear.&lt;h4>Methods&lt;/h4>The expression of serum exosomal DLEU1 was detected by quantitative real-time polymerase chain reaction (qRT-PCR). A receiver operating characteristic (ROC) curve was plotted to evaluate the clinical diagnostic efficacy of DLEU1. The Kaplan-Meier survival curve and Cox proportional hazards model were used to assess the effect of DLEU1 on postoperative recurrence, metastasis and prognosis among patients with CC.&lt;h4>Results&lt;/h4>Our research showed th</pubmed_abstract><journal>Annals of medicine</journal><pagination>2442537</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11654034</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The expression and clinical significance of serum exosomal-long non-coding RNA DLEU1 in patients with cervical cancer.</pubmed_title><pmcid>PMC11654034</pmcid><pubmed_authors>Zhao W</pubmed_authors><pubmed_authors>Xia Q</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Cui F</pubmed_authors><pubmed_authors>Wu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>The expression and clinical significance of serum exosomal-long non-coding RNA DLEU1 in patients with cervical cancer.</name><description>&lt;h4>Background&lt;/h4>Accumulating evidence has demonstrated that the long non-coding RNA (lncRNA) lymphocytic leukaemia deletion gene 1 (DLEU1) is abnormally overexpressed in many cancer types, including cervical cancer (CC). However, the potential clinical significance of DLEU1 in serum exosomes of patients with CC remains unclear.&lt;h4>Methods&lt;/h4>The expression of serum exosomal DLEU1 was detected by quantitative real-time polymerase chain reaction (qRT-PCR). A receiver operating characteristic (ROC) curve was plotted to evaluate the clinical diagnostic efficacy of DLEU1. The Kaplan-Meier survival curve and Cox proportional hazards model were used to assess the effect of DLEU1 on postoperative recurrence, metastasis and prognosis among patients with CC.&lt;h4>Results&lt;/h4>Our research showed th</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2025-04-26T17:00:16.518Z</modification><creation>2025-04-06T15:24:39.817Z</creation></dates><accession>S-EPMC11654034</accession><cross_references><pubmed>39687982</pubmed><doi>10.1080/07853890.2024.2442537</doi></cross_references></HashMap>